Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting preeclampsia.

W F O'Brien1

  • 1Department of Obstetrics and Gynecology, University of South Florida, College of Medicine, Tampa.

Obstetrics and Gynecology
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Identifying women at high risk for preeclampsia is crucial for effective treatment. Current efficient methods include family history, parity, and the roll-over test, with new lab tests showing future promise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cocaine decreases urinary prostacyclin release in pregnancy: correlation with uterine and umbilical Doppler velocimetry.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2004
Same author

Cocaine affects prostaglandin production in human umbilical cord cell cultures.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2004
Same author

Sulindac to prevent recurrent preterm labor: a randomized controlled trial.

Obstetrics and gynecology·2001
Same author

Tuberculosis in North Carolina: trends across two decades, 1980-1999.

Emerging infectious diseases·2001
Same author

Safety and efficacy of misoprostol orally and vaginally: a randomized trial.

Obstetrics and gynecology·2001
Same author

Histologic chorioamnionitis is associated with fetal growth restriction in term and preterm infants.

American journal of obstetrics and gynecology·2000
Same journal

A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

Obstetrics and gynecology·2026
Same journal

The Effects of Climate Change on Obstetric and Gynecologic Health.

Obstetrics and gynecology·2026
Same journal

PUBLICATIONS: July 2026.

Obstetrics and gynecology·2026
Same journal

Vaginal Natural Orifice Transluminal Endoscopic Surgery in Minimally Invasive Gynecologic Surgery: Correction.

Obstetrics and gynecology·2026
Same journal

A Contemporary View of Menopausal Hormone Therapy: Correction.

Obstetrics and gynecology·2026
Same journal

In Reply.

Obstetrics and gynecology·2026
See all related articles

Area of Science:

  • Obstetrics and Gynecology
  • Cardiovascular Research
  • Biomarkers in Pregnancy

Background:

  • Preeclampsia development may be influenced by drugs affecting prostacyclin and thromboxane.
  • Accurate patient selection is essential for the effective use of these therapeutic agents.
  • Risk stratification for preeclampsia is a significant clinical challenge.

Purpose of the Study:

  • To review historical, physical, and laboratory factors for predicting preeclampsia.
  • To identify the most efficient and widely available methods for preeclampsia risk assessment.
  • To evaluate promising new laboratory tests for early preeclampsia detection.

Main Methods:

  • Review of historical and physical examination findings.
  • Analysis of established laboratory tests for preeclampsia prediction.

Related Experiment Videos

  • Evaluation of novel biomarkers such as plasma fibronectin and urinary calcium/creatinine ratio.

    • Main Results:

    • Family history, parity, and the roll-over test are identified as efficient, accessible predictors.
    • Plasma fibronectin concentration shows potential as a future predictive biomarker.
    • Urinary calcium/creatinine ratio is another promising laboratory marker for preeclampsia risk.

    Conclusions:

    • Combining clinical factors with validated laboratory tests can improve preeclampsia prediction.
    • Early identification of high-risk pregnancies is key to timely intervention.
    • Further research into novel biomarkers like plasma fibronectin and urinary calcium/creatinine ratio is warranted.